Pharmanutra S.p.A. (BIT:PHN)

Italy flag Italy · Delayed Price · Currency is EUR
68.10
+1.40 (2.10%)
Mar 6, 2026, 5:35 PM CET
21.61%
Market Cap 653.98M
Revenue (ttm) 127.15M
Net Income (ttm) 17.45M
Shares Out 9.60M
EPS (ttm) 1.82
PE Ratio 37.45
Forward PE 28.87
Dividend 1.00 (1.50%)
Ex-Dividend Date May 5, 2025
Volume 38,826
Average Volume 19,504
Open 66.90
Previous Close 66.70
Day's Range 66.80 - 68.20
52-Week Range 38.75 - 68.20
Beta 0.30
RSI 62.88
Earnings Date Mar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar... [Read more]

Sector Healthcare
Founded 2003
Employees 136
Stock Exchange Borsa Italiana
Ticker Symbol PHN
Full Company Profile

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.

Financial Statements

News

There is no news available yet.